Codes / ICD10CM / E26.8

E26.8 Other hyperaldosteronism

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Other hyperaldosteronism

Summary

Other hyperaldosteronism refers to hyperaldosteronism that does not fall under primary or secondary classifications. It involves excessive aldosterone production from causes other than adrenal gland abnormalities or renin-mediated stimuli, leading to sodium retention, potassium loss, and elevated blood pressure. This imbalance can disrupt electrolyte levels and contribute to cardiovascular and renal complications.

Causes

The condition may result from rare adrenal or extra-adrenal sources of aldosterone overproduction, such as adrenal carcinoma, ectopic aldosterone-producing tumors, or genetic syndromes. Unlike primary or secondary forms, these causes are not driven by autonomous adrenal secretion or renin-angiotensin system activation.

Risk Factors

  • Adrenal carcinoma or rare adrenal tumors.
  • Ectopic aldosterone-producing tumors outside the adrenal glands.
  • Genetic syndromes affecting adrenal function.
  • Prior adrenal surgery or radiation exposure.

Symptoms

  • High blood pressure (hypertension).
  • Low potassium levels (hypokalemia).
  • Muscle weakness or cramps.
  • Fatigue and headaches.
  • Increased thirst or urination.

Diagnosis

Diagnosis involves blood tests to measure aldosterone and renin levels, electrolyte panels to assess potassium, and imaging studies (e.g., CT or MRI) to evaluate adrenal glands. Confirmatory tests may include urinary aldosterone excretion or adrenal vein sampling to identify rare or ectopic sources of excess hormone production.

Treatment Options

  • Medications such as spironolactone or eplerenone to block aldosterone effects.
  • Surgical removal of adrenal or ectopic tumors.
  • Management of underlying genetic or rare adrenal conditions.
  • Monitoring and adjustment of electrolyte levels.

Prognosis and Follow-Up

Prognosis depends on the underlying cause and timely treatment. Regular follow-up includes blood pressure monitoring, electrolyte checks, and imaging to assess for recurrence or progression. Early intervention can mitigate complications like hypertension or renal damage.

Complications

  • Severe hypertension leading to cardiovascular events.
  • Chronic hypokalemia causing muscle weakness or cardiac arrhythmias.
  • Renal impairment from prolonged electrolyte imbalances.
  • Adverse effects from long-term aldosterone-blocking medications.

Lifestyle & Prevention

  • Maintain a low-sodium diet to support blood pressure control.
  • Monitor potassium intake and avoid supplements unless directed.
  • Regular exercise and weight management to reduce hypertension risk.
  • Avoid over-the-counter medications that may affect electrolytes (e.g., certain diuretics).

When to Seek Professional Help

Seek medical attention if you experience persistent high blood pressure, unexplained muscle weakness, or symptoms of severe hypokalemia (e.g., palpitations, fatigue). Prompt evaluation is critical to identify and address underlying causes.

Tips for Medical Coders

Document the specific cause of hyperaldosteronism (e.g., adrenal carcinoma, ectopic tumor) to support the use of code E26.8. Include details on diagnostic tests, imaging findings, and treatment approaches to clarify the clinical context. Ensure documentation distinguishes this from primary or secondary forms to justify the "other" classification.

Book a walkthrough

E26.8 policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.